Brief: Axcella Granted Patent For Long Covid Fatigue Treatment
29/08/2023 13:06
Aug 29 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA GRANTED PATENT FOR LONG COVID FATIGUE TREATMENT
* AXCELLA THERAPEUTICS: PATENT WAS ISSUED ON AUGUST 29,
2023, WITH
ANTICIPATED EXPIRATION IN 2042
Source text for Eikon: ID:nBwc0vhl3a
Further company coverage: AXLA.O
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment